Managing chronic myeloid leukaemia in the elderly with intermittent imatinib treatment

The aim of this study was to investigate the effects of a non-standard, intermittent imatinib treatment in elderly patients with Philadelphia-positive chronic myeloid leukaemia and to answer the question on which dose should be used once a stable optimal response has been achieved. Seventy-six patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Russo, D, Malagola, M, Skert, C, Cancelli, V, Turri, D, Pregno, P, Bergamaschi, M, Fogli, M, Testoni, N, De Vivo, A, Castagnetti, F, Pungolino, E, Stagno, F, Breccia, M, Martino, B, Intermesoli, T, Cambrin, G R, Nicolini, G, Abruzzese, E, Tiribelli, M, Bigazzi, C, Usala, E, Russo, S, Russo-Rossi, A, Lunghi, M, Bocchia, M, D'Emilio, A, Santini, V, Girasoli, M, Lorenzo, R Di, Bernardi, S, Palma, A Di, Cesana, B M, Soverini, S, Martinelli, G, Rosti, G, Baccarani, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4648524/
https://www.ncbi.nlm.nih.gov/pubmed/26383820
http://dx.doi.org/10.1038/bcj.2015.75

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4648524/
https://www.ncbi.nlm.nih.gov/pubmed/26383820
http://dx.doi.org/10.1038/bcj.2015.75

Ejemplares similares